You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

6 Results
Guidelines and Advice
Status: Archived
ID: 14-3
Jul 2005
Guidelines and Advice
Status: Archived
ID: 13-7
Feb 2005
Guidelines and Advice
Status: Archived
ID: CED 1
Jun 2005
Guidelines and Advice
Status: Archived
ID: 12-4
Apr 2005
Guidelines and Advice
Status: Archived
ID: 2-20-2
Sep 2005
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Brentuximab Vedotin - Relapsed or Refractory Hodgkin Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
brentuximab vedotin,
bendamustine (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
New
Jan 2026